Work

Prospective Benefit-Risk Monitoring of New Drugs for Rapid Assessment of Net Favorability in Electronic Health Care Data

Year: 2015

Type: article

Study design: Observational Study

Source: Value in Health

DOI: 10.1016/j.jval.2015.08.011

Authors: Joshua J. Gagne, Katsiaryna Bykov, Mehdi Najafzadeh, Niteesh K. Choudhry, Diane P. Martin, Kristijan H. Kahler, James R. Rogers, Sebastian Schneeweiss

Institutions: Brigham and Women's Hospital, Harvard University, University of Washington

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Brigham and Women's Hospital, Harvard Catalyst, Novartis Pharmaceuticals Corporation, U.S. Food and Drug Administration

OpenAlex ID: W1943599847

FWCI: 0.529

Cites: 31

Cited by: 6

Related to: 10